Researchers continue to excited about the medication , a novel dual treatment showing remarkable outcomes in early trials for weight loss . It acts by modulating two pathways : GLP-1 and GIP, which , when https://sairakdje554864.newbigblog.com/47631511/the-new-hope-for-weight-management